Trials / Completed
CompletedNCT03380572
Initial Experience With a New Laparoscopic Based Robotically Assisted Surgical System for Cholecystectomy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Imperial College London · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The Senhance™ surgical robotic system, previously known as Telelap Alf-X (TransEnterix, Morrisville, NC, USA) has recently become available in the UK. It aims to provide the robotic benefits of greater accuracy, dexterity and control with similar operational costs to traditional laparoscopy. Patients randomly received either a standard laparoscopic cholecystectomy or the Senhance assisted cholecystectomy based on scheduled surgery date. A prospectively maintained database of the first 20 patients undergoing cholecystectomy with the Senhance Surgical System was retrospectively interrogated and compared to a concurrently treated group of 20 laparoscopically treated patients during the same timeframe.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Senhance Assisted Cholecystectomy | Cholecystectomy performed using Senhance surgical robotic system |
| PROCEDURE | Laparoscopic Cholecystectomy | Standard laparoscopic cholecystectomy |
Timeline
- Start date
- 2017-02-10
- Primary completion
- 2017-12-01
- Completion
- 2018-01-01
- First posted
- 2017-12-21
- Last updated
- 2019-05-21
- Results posted
- 2019-05-15
Locations
1 site across 1 country: United Kingdom
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03380572. Inclusion in this directory is not an endorsement.